The effect of pitavastatin on the lipoprotein subfraction profile and lipid metabolism

The effect of pitavastatin on the lipoprotein subfraction profile and lipid metabolism - PIT-STATION study

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCT1091220056

Enrollment

100

Registered

2011-01-27

Start date

2011-01-28

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

dyslipidemia, type 2 diabetes

Interventions

Intervention type:DRUG Name of intervention:pitavastatin Dose form / Japanese Medical Device Nomenclature:TABLET Route of administration / Site of application:ORAL Dose per administration: 1-4 mg Dosi

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: having dyslipidemia

Exclusion criteria

Exclusion criteria: liver dysfunction, renal dysfunction, heart failure, type 1 diabetes

Design outcomes

Primary

Measure	Time frame
Differences in the lipoprotein subfraction profiles between hyperlipidemic patients with and without type 2 diabetes	—

Secondary

Measure	Time frame
Differences in the lipoprotein subfraction profiles between hyperlipidemic patients with and without obesity	—

Countries

Japan

Contacts

Public ContactMasumi Ai

Tokyo Medical and Dental University

ai.bec@tmd.ac.jp+81-3-5803-4724

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026